IDRA News and Press, Idera Pharmaceuticals Inc.

Rare-disease-focused nano-cap biotech Idera Pharmaceuticals ( NASDAQ: IDRA ) fell ~22% on Tuesday after the company said that a 1-for-17 reverse stock split of its common stock would take effect when the market opens on January 18, 2023. Concurrently, Exton, Pennsylvania-based Ide...

Company completes preferred stock conversion, implements reverse stock split, and regains Nasdaq compliance Company positioned for success with late-stage rare disease portfolio and multiple clinical milestones in 2023 DURHAM, N.C. and EXTON, Pa., Jan. 17, 2023 (GLOBE NEWSWI...

Idera Pharmaceuticals press release ( NASDAQ: IDRA ): Q3 GAAP EPS of -$0.06. Revenue of $0.05M. The Company’s pro forma cash position as of September 30, 2022 was $26.8 million. For further details see: Idera Pharmaceuticals GAAP EPS of -$0.06, revenue...

EXTON, Pa. and DURHAM, N.C., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today reported its consolidated financial and operational results fo...

Idera Pharmaceuticals ( NASDAQ: IDRA ) has completed the acquisition of privately-held biotechnology company Aceragen in a stock-for-stock transaction. The acquisition, not subject to the approval of Idera stockholders, was unanimously approved by the board of both the com...

Acquisition includes late-stage rare disease portfolio with anticipated 2023 clinical milestones and first potential product approval as early as late 2024 Conference call and webcast today at 5:00 p.m. ET EXTON, Pa. and DURHAM, N.C., Sept. 28, 2022 (GLOBE NEWSWIRE) ...

Idera Pharmaceuticals press release ( NASDAQ: IDRA ): Q2 GAAP EPS of -$0.10. Shares +4% . Cash position as of June 30, 2022 was $24.5 million For further details see: Idera Pharmaceuticals GAAP EPS of -$0.10

EXTON, Pa., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today reported its financial and operational results for the second quarter ended Jun...

3 Top Tips For Buying Penny Stocks Right Now In the past few months, buying penny stocks has been difficult to say the least. With rising inflation, climbing interest rates, and geopolitical tensions, investing in penny stocks has not been for the faint of heart. However, because there ...

Are These Penny Stocks on Your Buy List Right Now? With another day of bearish trading patterns for penny stocks and blue chips, there is a lot for traders to know. As a result of the past few months of trading penny stocks , most investors are eager to see bullish trading patterns....